13Feb2015 How’s It Going at the Biotech Journalism Startup? Much Better Than Expected /Luke Timmerman/2/All, Diagnostics, Drugs, Genomics13 Feb 2015 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.